Influenza Vaccine To Prevent Adverse Vascular Events:Pilot
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 107 participants.
Also called NCT01945268
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 107 participants
- Registry
-
NCT01945268
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Mozambique, Philippines, Uganda
- Registry status
- Completed
Technical summary
Registry record NCT01945268. Randomized; quadruple masking; primary purpose treatment. Start 2015-04 (registry gives no type); primary completion 2015-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Influenza Vaccine To Prevent Adverse Vascular Events:Pilot
- Acronym
- IVVE:Pilot
- Condition
- Heart Failure
- Intervention (Drug)
- inactivated trivalent influenza vaccine
- Intervention (Other)
- Sterile saline
- Lead sponsor
- McMaster University
- Collaborator
- Population Health Research Institute
Record details
- Record id
cardio:ct-nct01945268- Content hash
fa14facb58d99117dd646a5c5cad1b054d67db0108d8d6fa511b3a0e9e780e2b